Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin

Archives of Pharmacal Research

Volumn 38, Issue 5, 2015, Pages 849-856

  Kwon, Mihwa ^a   Choi, Young A ^b   Choi, Min Koo ^b   Song, Im Sook ^a  

^a Kyungpook National University   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Berberine; Drug drug interaction; Metformin; OCT (organic cation transporter)

Indexed keywords

BERBERINE; METFORMIN; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; CATECHOLAMINE TRANSPORTER; ORGANIC CATION TRANSPORTER; SLC22A1 PROTEIN, RAT; SLC22A2 PROTEIN, RAT;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG INTERACTION; EFFECTIVE CONCENTRATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VIVO STUDY; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; VOLUME OF DISTRIBUTION; ANIMAL; BLOOD; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INTRAVENOUS; ANIMALS; BERBERINE; CATECHOLAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG INTERACTIONS; HEK293 CELLS; HUMANS; MALE; METFORMIN; ORGANIC CATION TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84929191341     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-014-0510-6     Document Type: Article

References (30)

1. Chang, W., M. Zhang, J. Li, Z. Meng, S. Wei, H. Du, L. Chen, and G.M. Hatch. 2013. Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase. Metabolism 62: 1159-1167.
2. Choi, M.K., Q.R. Jin, H.E. Jin, C.K. Shim, D.Y. Cho, J.G. Shin, and I.S. Song. 2007. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin. Biopharm Drug Dispos 28: 501-510.
3. Choi, M.K., and I.S. Song. 2008. Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metabolism and Pharmacokinetics 23: 243-253.
4. Choi, Y.H., S.G. Kim, and M.G. Lee. 2006. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects. Journal of Pharmaceutical Science 95: 2543-2552.
5. Choi, Y.H., and M.G. Lee. 2006. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: Involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. British Journal of Pharmacology 149: 424-430.
6. Choi, Y.H., U. Lee, B.K. Lee, and M.G. Lee. 2010. Pharmacokinetic interaction between itraconazole and metformin in rats: Competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2. British Journal of Pharmacology 161: 815-829.
7. Dong, H., N. Wang, L. Zhao, and F. Lu. 2012. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine 2012: 591654.
8. Giacomini, K.M., S.M. Huang, D.J. Tweedie, L.Z. Benet, K.L. Brouwer, X. Chu, A. Dahlin, R. Evers, V. Fischer, K.M. Hillgren, K.A. Hoffmaster, T. Ishikawa, D. Keppler, R.B. Kim, C.A. Lee, M. Niemi, J.W. Polli, Y. Sugiyama, P.W. Swaan, J.A. Ware, S.H. Wright, S.W. Yee, M.J. Zamek-Gliszczynski, and L. Zhang. 2010. Membrane transporters in drug development. Nature Reviews Drug Discovery 9: 215-236.
9. Guo, Y., Y. Chen, Z.R. Tan, C.D. Klaassen, and H.H. Zhou. 2012. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology 68: 213-217.
10. Han, Y., Q. Wang, P. Song, Y. Zhu, and M.H. Zou. 2010. Redox regulation of the AMP-activated protein kinase. PLoS One 5: e15420.
11. Hua, W., L. Ding, Y. Chen, B. Gong, J. He, and G. Xu. 2007. Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 44: 931-937.
12. Jin, H.E., S.S. Hong, M.K. Choi, H.J. Maeng, D.D. Kim, S.J. Chung, and C.K. Shim. 2009. Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis. Pharmaceutical Research 26: 549-559.
13. Kim, H.S., M.J. Kim, E.J. Kim, Y. Yang, M.S. Lee, and J.S. Lim. 2012. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochemical Pharmacology 83: 385-394.
14. Koepsell, H., K. Lips, and C. Volk. 2007. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharmaceutical Research 24: 1227-1251.
15. Krausova, L., L. Stejskalova, H. Wang, R. Vrzal, Z. Dvorak, S. Mani, and P. Pavek. 2011. Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. Biochemical Pharmacology 82: 1771-1780.
16. Liu, L.Z., S.C. Cheung, L.L. Lan, S.K. Ho, H.X. Xu, J.C. Chan, and P.C. Tong. 2010a. Berberine modulates insulin signaling transduction in insulin-resistant cells. Molecular and Cellular Endocrinology 317: 148-153.
17. Liu, Y.T., H.P. Hao, H.G. Xie, L. Lai, Q. Wang, C.X. Liu, and G.J. Wang. 2010b. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metabolism and Disposition 38: 1779-1784.
18. Nies, A.T., E. Herrmann, M. Brom, and D. Keppler. 2008. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn-Schmiedeberg Archives of Pharmacology 376: 449-461.
19. Prabhakar, P.K., and M. Doble. 2009. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine 16: 1119-1126.
20. Ryu, J.Y., I.S. Song, Y.E. Sunwoo, J.H. Shon, K.H. Liu, I.J. Cha, and J.G. Shin. 2007. Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo. Clinical Pharmacology & Therapeutics 82: 531-540.
21. Shu, Y., S.A. Sheardown, C. Brown, R.P. Owen, S. Zhang, R.A. Castro, A.G. Ianculescu, L. Yue, J.C. Lo, E.G. Burchard, C.M. Brett, and K.M. Giacomini. 2007. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. Journal of Clinical Investigation 117: 1422-1431.
22. Tucker, G.T., C. Casey, P.J. Phillips, H. Connor, J.D. Ward, and H.F. Woods. 1981. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. British Journal of Clinical Pharmacology 12: 235-246.
23. Wang, D.S., H. Kusuhara, Y. Kato, J.W. Jonker, A.H. Schinkel, and Y. Sugiyama. 2003. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Molecular Pharmaceutics 63: 844-848.
24. Wang, Y., T. Campbell, B. Perry, C. Beaurepaire, and L. Qin. 2011. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 60: 298-305.
25. Wu, X., Q. Li, H. Xin, A. Yu, and M. Zhong. 2005. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: Clinical and pharmacokinetic study. European Journal of Clinical Pharmacology 61: 567-572.
26. Yin, J., H. Xing, and J. Ye. 2008. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57: 712-717.
27. Zhang, H., J. Wei, R. Xue, J.D. Wu, W. Zhao, Z.Z. Wang, S.K. Wang, Z.X. Zhou, D.Q. Song, Y.M. Wang, H.N. Pan, W.J. Kong, and J.D. Jiang. 2010. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 59: 285-292.
28. Zhang, S., K.S. Lovejoy, J.E. Shima, L.L. Lagpacan, Y. Shu, A. Lapuk, Y. Chen, T. Komori, J.W. Gray, X. Chen, S.J. Lippard, and K.M. Giacomini. 2006. Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Research 66: 8847-8857.
29. Zhang, Y., X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, G. Ren, and G. Ning. 2008. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology and Metabolism 93: 2559-2565.
30. Zhao, Y., B.H. Hellum, A. Liang, and O.G. Nilsen. 2012. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine. Phytotherapy Research 26: 277-283.